(Q41112958)

26 September 2017

1 reference

title

Hydrolytic antibodies: variations on a theme (English)

1 reference

26 September 2017

MacBeath G

1

1 reference

PubMed ID

8807874

26 September 2017

Hilvert D

series ordinal

2

1 reference

26 September 2017

1 June 1996

1 reference

26 September 2017

Chemistry and Biology

1 reference

26 September 2017

3

1 reference

26 September 2017

433-445

1 reference

26 September 2017

6

1 reference

At the crossroads of chemistry and immunology: catalytic antibodies

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

From molecular diversity to catalysis: lessons from the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Phosphonamidates as transition-state analogue inhibitors of thermolysin.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Peptidic phosphonylating agents as irreversible inhibitors of serine proteases and models of the tetrahedral intermediates.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Crystal structure of a catalytic antibody Fab with esterase-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Crystal structure of a catalytic antibody with a serine protease active site

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Development of the primary antibody repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Evolutionary and somatic selection of the antibody repertoire in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Transition-state characterization: a new approach combining inhibitor analogs and variation in enzyme structure

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

The immunological evolution of catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

The enzymic nature of antibody catalysis: development of multistep kinetic processing

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Induction of an Antibody That Catalyzes the Hydrolysis of an Amide Bond

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Site-directed mutagenesis of a catalytic antibody: an arginine and a histidine residue play key roles

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Detection of a catalytic antibody species acylated at the active site by electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 2. Structural basis of hapten binding and idiotypy.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Somatic mutation and the maturation of immune response to 2-phenyl oxazolone

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Structural and kinetic studies of the Fab fragment of a monoclonal anti-spin label antibody by nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

The Imprint of Somatic Hypermutation on the Repertoire of Human Germline V Genes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Dissecting the catalytic triad of a serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Subtilisin--an enzyme designed to be engineered

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Selection of human anti-hapten antibodies from semisynthetic libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Glubodies: randomized libraries of glutathione transferase enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

1 reference

7 January 2021

Transition-state stabilization as a measure of the efficiency of antibody catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2896%2990091-5

7 January 2021

10.1016/S1074-5521(96)90091-5

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8807874